Ilse Schwarzinger

5.6k total citations
136 papers, 4.0k citations indexed

About

Ilse Schwarzinger is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ilse Schwarzinger has authored 136 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hematology, 40 papers in Genetics and 27 papers in Molecular Biology. Recurrent topics in Ilse Schwarzinger's work include Acute Myeloid Leukemia Research (51 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Hematopoietic Stem Cell Transplantation (22 papers). Ilse Schwarzinger is often cited by papers focused on Acute Myeloid Leukemia Research (51 papers), Chronic Myeloid Leukemia Treatments (29 papers) and Hematopoietic Stem Cell Transplantation (22 papers). Ilse Schwarzinger collaborates with scholars based in Austria, United States and Germany. Ilse Schwarzinger's co-authors include Klaus Lechner, Ulrich Jäger, Renate Thalhammer-Scherrer, Ulrich Jaeger, Christa Fonatsch, Peter Valent, Gerlinde Mitterbauer, Ingrid Pabinger, Oswald Wagner and Christine Mannhalter and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Ilse Schwarzinger

133 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilse Schwarzinger Austria 36 1.8k 1.2k 914 840 733 136 4.0k
Chihiro Shimazaki Japan 33 2.4k 1.4× 1.5k 1.2× 813 0.9× 1.2k 1.5× 659 0.9× 213 4.0k
G.J. Ossenkoppele Netherlands 34 1.6k 0.9× 783 0.7× 677 0.7× 1.1k 1.4× 607 0.8× 84 3.3k
Lee‐Yung Shih Taiwan 30 1.7k 1.0× 1.2k 1.0× 776 0.8× 663 0.8× 347 0.5× 195 3.6k
Stefan Hohaus Italy 39 1.5k 0.9× 1.4k 1.2× 591 0.6× 1.4k 1.6× 913 1.2× 167 4.2k
Sang Kyun Sohn South Korea 28 1.4k 0.8× 600 0.5× 567 0.6× 723 0.9× 719 1.0× 191 2.7k
Kazimierz Kuliczkowski Poland 29 1.2k 0.7× 1.1k 0.9× 1.1k 1.2× 1.2k 1.5× 978 1.3× 202 3.5k
Dina Ben‐Yehuda Israel 35 1.7k 1.0× 2.1k 1.7× 1.2k 1.3× 1.3k 1.5× 579 0.8× 124 4.8k
Yasushi Takamatsu Japan 27 1.6k 0.9× 695 0.6× 549 0.6× 1.3k 1.6× 1.1k 1.5× 159 3.6k
Francesco Buccisano Italy 36 3.1k 1.8× 1.6k 1.3× 1.5k 1.6× 702 0.8× 765 1.0× 186 4.8k
Sally Arai United States 35 2.4k 1.4× 1.1k 0.9× 548 0.6× 1.2k 1.5× 1.5k 2.1× 149 4.4k

Countries citing papers authored by Ilse Schwarzinger

Since Specialization
Citations

This map shows the geographic impact of Ilse Schwarzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Schwarzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Schwarzinger more than expected).

Fields of papers citing papers by Ilse Schwarzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse Schwarzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Schwarzinger. The network helps show where Ilse Schwarzinger may publish in the future.

Co-authorship network of co-authors of Ilse Schwarzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Schwarzinger. A scholar is included among the top collaborators of Ilse Schwarzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Schwarzinger. Ilse Schwarzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greiner, Georg, Rodrig Marculescu, Karoline V. Gleixner, et al.. (2023). N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia. American Journal of Hematology. 98(2). 290–299. 5 indexed citations
2.
Demyanets, Svitlana, Alexandra Kaider, Ingrid Simonitsch‐Klupp, et al.. (2020). Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response. Annals of Hematology. 99(11). 2599–2609. 4 indexed citations
3.
Simbrunner, Benedikt, Helmuth Haslacher, David Bauer, et al.. (2019). Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. United European Gastroenterology Journal. 7(5). 651–661. 7 indexed citations
4.
Porpaczy, Edit, et al.. (2018). Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib. British Journal of Haematology. 181(4). 431–431. 1 indexed citations
5.
Einwallner, Elisa, Gerlinde Mitterbauer‐Hohendanner, Martin Bilban, et al.. (2013). Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia: A Recurrent Finding Associated with Persistent Minimal Residual Disease Under Imatinib. Stem Cells and Development. 22(23). 3043–3051. 1 indexed citations
6.
Mayerhofer, Matthias, Karoline V. Gleixner, Andrea Hoelbl‐Kovacic, et al.. (2008). Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens. The Journal of Immunology. 180(8). 5466–5476. 58 indexed citations
7.
Wimazal, Friedrich, Wolfgang R. Sperr, Michael Kundi, et al.. (2008). Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Annals of Oncology. 19(5). 970–976. 33 indexed citations
8.
Streubel, Berthold, et al.. (2008). Dasatinib inhibits progenitor cell proliferation from polycythaemia vera. European Journal of Clinical Investigation. 38(8). 578–584. 7 indexed citations
9.
Grisar, Johannes, Daniel Aletaha, C. W. Steiner, et al.. (2007). Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Annals of the Rheumatic Diseases. 66(10). 1284–1288. 75 indexed citations
10.
Streubel, Berthold, Andreas Chott, Daniela Hüber, et al.. (2004). Lymphoma-Specific Genetic Aberrations in Microvascular Endothelial Cells in B-Cell Lymphomas. New England Journal of Medicine. 351(3). 250–259. 249 indexed citations
11.
Valent, Peter, Christa Fonatsch, Reinhard Stindl, et al.. (2003). Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype. Leukemia Research. 28(6). 651–655. 4 indexed citations
12.
Weltermann, A., Christa Fonatsch, Oskar A. Haas, et al.. (2003). Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse. Leukemia. 18(2). 293–302. 51 indexed citations
13.
Bergler‐Klein, Jutta, Paul Knoebl, Berthold Streubel, et al.. (2003). Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography. 16(12). 1326–1330. 7 indexed citations
14.
Thalhammer-Scherrer, Renate, Klaus Geißler, Ilse Schwarzinger, et al.. (2000). Fludarabine therapy in Waldenström's macroglobulinemia. Annals of Hematology. 79(10). 556–559. 26 indexed citations
15.
Mitterbauer, Gerlinde, Christine L. Zimmer, Hendrati Pirc‐Danoewinata, et al.. (2000). Monitoring of minimal residual disease in patients with MLL–AF6‐positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction. British Journal of Haematology. 109(3). 622–628. 25 indexed citations
16.
Weltermann, A., Ingrid Pabinger, Klaus Geißler, et al.. (1998). Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis. Leukemia. 12(8). 1182–1186. 13 indexed citations
17.
Reiter, Elisabeth, Hildegard Greinix, Gerlinde Mitterbauer, et al.. (1998). Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia. Annals of Hematology. 77(6). 283–286. 2 indexed citations
18.
Schwarzinger, Ilse, Manuela Födinger, R. Scherrer, et al.. (1993). Hypergranular acute lymphoblastic leukemia (ALL). Annals of Hematology. 67(6). 301–303. 5 indexed citations
19.
Grois, Nicole, G. Mostbeck, R. Scherrer, et al.. (1991). Hepatic and splenic abscesses — a common complication of intensive chemotherapy of acute myeloid leukemia (AML). Annals of Hematology. 63(1). 33–38. 14 indexed citations
20.
Schwarzinger, Ilse, Peter Valent, Ursula Köller, et al.. (1990). Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.. Journal of Clinical Oncology. 8(3). 423–430. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026